ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 175 filers reported holding ANI PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.82 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $1,321,000 | -54.3% | 21,418 | -46.0% | 0.08% | -44.5% |
| Q3 2019 | $2,891,000 | -25.9% | 39,668 | -16.4% | 0.14% | -21.3% |
| Q2 2019 | $3,902,000 | +15.8% | 47,468 | -0.6% | 0.17% | +33.8% |
| Q1 2019 | $3,370,000 | +58.7% | 47,768 | +1.3% | 0.13% | +51.2% |
| Q4 2018 | $2,123,000 | -5.1% | 47,153 | +19.2% | 0.09% | +30.3% |
| Q3 2018 | $2,237,000 | -12.0% | 39,558 | +3.9% | 0.07% | -15.4% |
| Q2 2018 | $2,543,000 | +133.3% | 38,075 | +103.4% | 0.08% | +122.9% |
| Q1 2018 | $1,090,000 | -25.1% | 18,720 | -17.1% | 0.04% | -20.5% |
| Q4 2017 | $1,455,000 | +22.8% | 22,570 | 0.0% | 0.04% | +18.9% |
| Q3 2017 | $1,185,000 | +27.7% | 22,570 | +13.8% | 0.04% | +48.0% |
| Q2 2017 | $928,000 | +8.0% | 19,825 | +14.2% | 0.02% | 0.0% |
| Q1 2017 | $859,000 | -14.1% | 17,360 | +5.2% | 0.02% | -7.4% |
| Q4 2016 | $1,000,000 | +23.6% | 16,500 | +35.2% | 0.03% | +22.7% |
| Q3 2016 | $809,000 | – | 12,200 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 200,000 | $13,270,000 | 21.02% |
| Healthcare Value Capital, LLC | 50,000 | $3,318,000 | 5.26% |
| Consonance Capital Management LP | 653,258 | $43,344,000 | 4.17% |
| 1492 Capital Management LLC | 34,500 | $2,289,000 | 1.87% |
| JW Asset Management, LLC | 29,722 | $1,972,000 | 1.36% |
| FRANKLIN STREET ADVISORS INC /NC | 29,000 | $1,924,000 | 0.35% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 55,705 | $3,696,000 | 0.27% |
| Ativo Capital Management LLC | 15,805 | $1,049,000 | 0.24% |
| DIKER MANAGEMENT LLC | 9,810 | $651,000 | 0.23% |
| CASTLEARK MANAGEMENT LLC | 100,615 | $6,676,000 | 0.20% |